DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Ubenimex
Ubenimex
United States Patent (10) Patent No.: US 7,351,739 B2 H0 Et Al
(12) United States Patent (10) Patent No.: US 8,501450 B2 N-N-1
Stems for Nonproprietary Drug Names
Antitumor Activity of Actinonin in Vitro and in Vivo
Annual Report 2016
Etude De L'interaction Entre 14-3-3 Epsilon Et CD13/APN Dans La
Prediction and Evaluation of Protein Farnesyltransferase Inhibition by Commercial Drugs
Neutral Metalloaminopeptidases APN and Metap2 As Newly Discovered Anticancer Molecular Targets of Actinomycin D and Its Simple Analogs
WO 2018/096100 Al 31 May 2018 (31.05.2018) W !P O PCT
Eiger Announces Results Demonstrating Benefit of Ubenimex
Inhibiting the Breakdown of Endogenous Opioids and Cannabinoids to Alleviate Pain
Stembook 2018.Pdf
Inhibiting the Breakdown of Endogenous Opioids and Cannabinoids to Alleviate Pain
Report the Production, Isolation, Physico-Chemical Prop
Ubenimex Inhibits Cell Proliferation, Migration and Invasion in Renal Cell Carcinoma: the Effect Is Autophagy-Associated
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
ICCB-L Plate (10 Mm / 3.33 Mm) ICCB-L Well Vendor ID Chemical Name
Influence of Bestatin, an Inhibitor of Aminopeptidases, on T and B Lymphocyte Subsets in Mice
Top View
Pharmacology and Toxicology
(12) United States Patent (10) Patent No.: US 8,026,254 B2 Chen (45) Date of Patent: Sep
A Full Cycle Anti-Viral Drug Screen Identifies a Clinical Compound
COMP Agenda of the 17-19 July 2018 Meeting
Charles M. Lizza William C. Baton Sarah A. Sullivan One
Eiger Announces First Patient Dosed in Open-Label Extension of Phase 2 LIBERTY Study of Ubenimex in Pulmonary Arterial Hypertension (PAH)
(12) Patent Application Publication (10) Pub. No.: US 2011/0059886 A1 Lin Et Al
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
(12) Patent Application Publication (10) Pub. No.: US 2017/0056347 A1 Glick Et Al
286-6700
[email protected]
Tepzz 5 58¥Zb T
(12) Patent Application Publication (10) Pub. No.: US 2003/0022909 A1 MOSS Et Al
WO 2017/136652 Al 10 August 2017 (10.08.2017) P O P C T
(12) United States Patent (10) Patent No.: US 9,198.866 B2 Bhat Et Al
Discontinued Drugs for the Treatment of Cardiovascular Disease from 2016 to 2018
Ep 2620429 A1
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Ubenimex Induces Apoptotic and Autophagic Cell Death in Rat GH3 and MMQ Cells Through the ROS/ERK Pathway
Aminopeptidase
Antibodies Products
Qt5vp5h8g4 Nosplash A8f7ec4
The Rational Design of Therapeutic Peptides for Aminopeptidase N Using a Substrate-Based Approach Received: 7 November 2016 Shilvi Joshi1, Lang Chen 1, Michael B